Corrigendum to "The 0.19-mg Fluocinolone Acetonide Intravitreal Implant Reduces Treatment Burden in Diabetic Macular Edema" [Am J Ophthalmol 2023;248;16-23]
Am J Ophthalmol
.
2023 Aug:252:336.
doi: 10.1016/j.ajo.2023.05.001.
Epub 2023 May 22.
Authors
Pauline T Merrill
1
,
Nancy Holekamp
2
,
Daniel Roth
3
,
Jonathan Kasper
4
,
Ruben Grigorian
5
;
PALADIN Study Group
Affiliations
1
From the Department of Ophthalmology, Rush University, Chicago, Illinois (P.T.M.). Electronic address: pauline.merrill@gmail.com.
2
Pepose Vision Institute, Chesterfield, Missouri (N.H.).
3
Department of Ophthalmology, Rutgers-Robert Wood Johnson Medical School, New Brunswick, New Jersey (D.R.).
4
Alimera Sciences, Inc, Alpharetta, Georgia, (J.K.).
5
Northeast Louisiana Retina Eye Center, West Monroe, Louisiana (R.G.), USA.
PMID:
37225642
DOI:
10.1016/j.ajo.2023.05.001
No abstract available
Publication types
Published Erratum